LOGIN  |  REGISTER

Recent Insider Transactions - Prelude Therapeutics (NASDAQ: PRLD)

Follow NASDAQ:PRLD Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ PRLD Prelude Therapeutics
Huang Jane / officer: President, CMO
04/04/2025
Sell
$0.68
3,355
$2K
74,877
NASDAQ PRLD Prelude Therapeutics
Combs Andrew / officer: Chief Chemistry Officer
03/25/2025
Buy
$0.69
100,000
$69K
480,123
NASDAQ PRLD Prelude Therapeutics
Vaddi Krishna / director, officer: CEO
03/25/2025
Buy
$0.69
675,000
$467K
2.00M
NASDAQ PRLD Prelude Therapeutics
Vaddi Krishna / director, officer: CEO
03/21/2025
Buy
$0.73
15,000
$11K
1.32M
NASDAQ PRLD Prelude Therapeutics
Vaddi Krishna / director, officer: CEO
03/20/2025
Buy
$0.73
5,416
$4K
1.31M
NASDAQ PRLD Prelude Therapeutics
Vaddi Krishna / director, officer: CEO
03/17/2025
Buy
$0.75
9,106
$7K
1.30M
NASDAQ PRLD Prelude Therapeutics
Vaddi Krishna / director, officer: CEO
03/14/2025
Buy
$0.75
29,999
$23K
1.29M
NASDAQ PRLD Prelude Therapeutics
Vaddi Krishna / director, officer: CEO
03/13/2025
Buy
$0.72
50,000
$36K
1.26M
NASDAQ PRLD Prelude Therapeutics
Vaddi Krishna / director, officer: CEO
03/12/2025
Buy
$0.71
47,500
$34K
1.21M

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous